68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label positron emission tomography/computed tomography (PET/CT) study to
investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-BBN-RGD in
prostate cancer patients. A single dose of 111-148 Mega-Becquerel (MBq) 68Ga-NOTA-BBN-RGD
will be injected intravenously. Visual and semiquantitative method will be used to assess the
PET/CT images.
Phase:
Early Phase 1
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborator:
National Institute for Biomedical Imaging and Bioengineering (NIBIB)